Siam Bioscience reports record profit after COVID vaccine deal with AstraZeneca Ruchika Sharma29 Aug 2022 10:45 AM ISTBangkok: Thai drugmaker Siam Bioscience, owned by the country's king, reported a near 50-fold increase in annual profit in 2021, when it began...
Alleging patent infringement, Moderna sues Pfizer-BioNtech over use of mRNA technology in COVID vaccine Ruchika Sharma27 Aug 2022 5:00 PM ISTPfizer said the company was confident in its intellectual property and would vigorously defend against the allegations.
Novavax COVID vaccine Nuvaxovid gets expanded conditional marketing nod in UK for adolescents aged 12 through 17 Ruchika Sharma27 Aug 2022 11:15 AM ISTGaithersburg: Novavax, Inc. has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom (UK) has granted...
COVID vaccine 73.2 percent effective in children under 5: Pfizer Ruchika Sharma24 Aug 2022 4:30 PM ISTThe Pfizer-BioNTech COVID-19 Vaccine, which is based on BioNTech's proprietary mRNA technology, was developed by both BioNTech and Pfizer.
AstraZeneca may not stay in vaccine business in long run: CEO Ruchika Sharma24 Aug 2022 2:57 PM ISTAstraZeneca is also looking for bolt-on acquisitions, including small and mid-sized companies specialising in oncology and cardiovascular treatments,...
Moderna seeks USFDA nod for COVID booster tailored against Omicron subvariants Ruchika Sharma24 Aug 2022 1:15 PM ISTThe submission also includes clinical trial data for its BA.1 Omicron-targeting bivalent booster candidate, which was last week cleared in Britain.
Pfizer, BioNTech seek USFDA emergency use nod for Omicron adapted COVID booster dose for 12 years of age and older Ruchika Sharma23 Aug 2022 11:32 AM ISTThe bivalent vaccine contains mRNA encoding the original SARS-CoV-2 spike protein, which is present in the original Pfizer-BioNTech COVID-19 Vaccine,...
Novavax COVID vaccine Nuvaxovid gets provisional nod in New Zealand for adolescents aged 12 through 17 Ruchika Sharma22 Aug 2022 1:45 PM ISTNuvaxovid (NVX-CoV2373) is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes...
Novavax COVID vaccine Adjuvanted gets USFDA emergency use authorization for adolescents aged 12 through 17 Ruchika Sharma22 Aug 2022 12:15 PM ISTNVX-CoV2373 is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes COVID-19 disease.
Moderna to supply 12 million doses of Omicron containing bivalent COVID booster vaccines to Govt of Canada Ruchika Sharma22 Aug 2022 9:30 AM ISTCambridge: Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the Government...
Test second Paxlovid course in patients with COVID rebound: USFDA asks Pfizer Ruchika Sharma21 Aug 2022 11:30 AM ISTBengaluru: The U.S. Food and Drug Administration (USFDA) has asked Pfizer Inc to test the effects of an additional course of its antiviral Paxlovid...
Valneva COVID vaccine recommended by WHO Roshni Dhar20 Aug 2022 6:45 PM ISTThe World Health Organization (WHO) on Thursday recommended the use of French drugmaker Valneva's COVID-19 vaccine. The UN agency also recommended the...
